Loading blog post…
A guide to temple filler — why temple volume loss ages the face significantly, how filler treatment works, the vascular risk in the temporal region, realistic results, and cost.
· By MedSpot Editorial · 5 min read
#injectables · #fillers · #face · #guide
Temple hollowing is one of the most underestimated contributors to facial aging. Patients who come in complaining about looking "gaunt," "skeletal," or "tired" despite having adequate mid-face volume often have significant temporal volume loss that they haven't noticed specifically — because the temples aren't an area most people study in the mirror.
The temporal fossa (temple area) forms the upper lateral boundary of the face. When full, it creates:
When hollow, the temples create:
This skeletonized appearance is strongly associated with advanced aging and illness — which is why treating it produces a rejuvenating effect that can't be achieved by treating other areas alone.
Temple hollowing is driven by fat pad atrophy (the temporal fat pad, like other facial fat compartments, diminishes with age) and some degree of temporal muscle reduction. It begins in the 30s and becomes more pronounced through the 40s and 50s.
Patients who are very lean or athletes often develop early and more pronounced temporal hollowing because they have less overall body fat including facial fat.
Product choice: Thick, structural fillers are appropriate for the temple because the volume needed can be significant (1–3 mL per side in some cases) and the area is over a bony surface:
Injection approach: Two main techniques:
Supraperiosteal (deep) injection: Filler placed directly on the bone surface. Structurally sound; least vascular risk because it's below the superficial temporal vessels.
Intramuscular or subcutaneous injection: Higher layers; can look more natural but carries higher vascular risk because the middle temporal vein and superficial temporal artery run in this zone.
Most experienced injectors use a combination approach, placing the majority of product at the bone and a smaller amount more superficially for contouring.
The temporal region contains the middle temporal vein (a significant vessel that runs through the temporal fat) and the superficial temporal artery (a branch of the external carotid that crosses the temple superficially). Vascular occlusion in this area has caused skin necrosis and, in rare reported cases, retinal artery occlusion (vision loss) through retrograde flow.
This makes the temple an area where:
The risk is real but low when performed by properly trained providers. It is not a reason to avoid treatment — it is a reason to select your provider carefully.
Volume: Most patients need 1–2 mL per side for meaningful improvement; patients with severe hollowing may need 2–3 mL per side. With Sculptra, volume is achieved over 3 sessions.
Immediate result: Immediate improvement visible. The full integration and any swelling resolution takes 2–4 weeks for HA fillers; 3–6 months for Sculptra.
Duration: Voluma/Lyft in the temples: 18–24 months (longer than in more mobile areas). Sculptra: 2–3 years.
Session: 20–30 minutes. Topical numbing is applied; some providers use lidocaine in the dilution or a local nerve block.
Downtime: Mild bruising possible; tenderness for 1–3 days.
| Treatment | Volume | Cost |
|---|---|---|
| Mild hollowing (both temples) | 1–2 mL total | $800–$2,000 |
| Moderate hollowing (both temples) | 2–4 mL total | $2,000–$4,000 |
| Sculptra (course of 3 sessions) | 3–6 vials | $2,100–$5,000 |
A patient who comes in asking about nasolabial folds, jowling, or "looking tired" may hear their injector recommend starting with temple filler rather than directly treating the presenting complaint. This is often correct:
This is a sign of a sophisticated injector who thinks about the face as a whole rather than treating one complaint in isolation.
Looking for a filler specialist near you? Browse injectable providers on MedSpot →